Skip to main content

Post-IPO Equity Companies in Redwood City

Explore 8 post-ipo equity startups based in Redwood City, United States. Access verified founder contact information and fundraising data.

Total Companies
8
Total Funding
$2.3B
Avg Funding
$285.9M
Industries
4

Export 8 Post-IPO Equity Companies in Redwood City

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Biopharma
$150.0M
raised

Allakos is a biotechnology company developing therapeutic antibodies targeting allergy, inflammatory and proliferative diseases.

Sep 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Biotechnology
$132.0M
raised

Jasper Therapeutics is a biotechnology company that develops novel antibody therapies for stem cell transplants.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)
$150.0M
raised

Serve Robotics designs and operates autonomous sidewalk delivery robots focused on last-mile food and retail logistics.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

$1.5B
raised

Revolution Medicines is an innovative and dynamic organization of expert biologists, chemists, pharmacologists, clinical scientists.

Apr 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Biotechnology
$50.1M
raised

Coherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 8 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Biopharma
$200.0M
raised

Arcellx develops engineered cell-based immunotherapies for the treatment of cancer and other serious diseases.

Nov 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Biotechnology
$25.0M
raised

Biomea Fusion is a precision oncology company developing novel small molecules that target aggressive forms of cancer.

Oct 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Biopharma
$80.0M
raised

Adicet Bio is a biotechnology company discovering and developing first-in-class allogeneic gamma delta CAR t cell therapies for cancer

Oct 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Connect with Post-IPO Equity Startups in Redwood City?

Get verified founder emails, funding details, and company data for 8 post-ipo equity companies in Redwood City.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked